1. Introduction and Mechanism of Action for Nexletol Nexletol is a novel oral lipid lowering medication utilized to treat specific forms of severe hypercholesterolemia. The active ingredient, bempedoic acid, is an adenosine triphosphate citrate lyase inhibitor. This enzyme acts upstream of HMG-CoA reductase in the cholesterol biosynthesis pathway within the liver. By inhibiting this specific … Read more
1. Introduction and Mechanism of Action for Nexlizet Nexlizet is a potent oral prescription medication designed to aggressively lower blood cholesterol levels by combining two distinct lipid lowering agents. Bempedoic acid inhibits cholesterol synthesis in the liver while ezetimibe blocks the absorption of dietary cholesterol in the digestive tract. The most notable side effect of … Read more
1. Introduction to Elevated Low-Density Lipoprotein A laboratory finding indicating that low-density lipoprotein cholesterol is above the reference range is a critical clinical marker signaling an increased risk for cardiovascular disease. Low-density lipoprotein, commonly referred to as the “bad” cholesterol, is a primary vehicle for transporting lipids through the bloodstream. While essential for normal cellular … Read more
1. Introduction Hypercholesterolemia is a highly prevalent metabolic disorder characterized by an excessive concentration of cholesterol, specifically low-density lipoprotein cholesterol, circulating within the bloodstream. Cholesterol itself is not an inherent toxin; it is an absolutely essential lipid required for the structural integrity of every cellular membrane in the body, the synthesis of vital steroid hormones, … Read more